Last reviewed · How we verify
SUP Articaine
At a glance
| Generic name | SUP Articaine |
|---|---|
| Also known as | Articadent (Dentsply Pharmaceutical) |
| Sponsor | University of Michigan |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Efficacy Study of Articaine Versus Lidocaine as Supplemental Infiltration in Inflamed Molars (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- SUP Articaine CI brief — competitive landscape report
- SUP Articaine updates RSS · CI watch RSS
- University of Michigan portfolio CI